Clinical Trials Directory

Trials / Completed

CompletedNCT05450497

Effect of Sedative Agent on Reducing the Frequency of Arrhythmia in the Patients After Cardiac Surgery

Effect of Propofol vs Dexmedetomidine or Propofol+Dexmedetomidine on Reducing the Frequency of Arrhythmia in Patients After Cardiac Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
356 (actual)
Sponsor
Anesthesia Research Group UA · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Arrhythmias early in the recovery period after cardio thoracic surgery are common they develop in 11 to 40 percent of patients after coronary-artery bypass grafting. The right chose of sedative agent could decrease the level of arrhythmia incidence.

Detailed description

Arrhythmias are really common in patients after cardiac surgery. Most of the patients get sedation after cardiac surgery. The goal is to determine if the propofol (PR) (sedative agent), dexmedetomidine (DEX)(selective α2-adrenergic receptor (α2-AR) agonist) or their combination could improve and decrease the incidence of the arrhythmia in patients after cardiac surgery.

Conditions

Interventions

TypeNameDescription
DRUGPropofolcomparing sedative agents
DRUGDexmedetomidinecomparing sedative agents
DRUGDexmedetomidine and propofolcomparing sedative agents

Timeline

Start date
2017-07-01
Primary completion
2019-07-01
Completion
2019-07-01
First posted
2022-07-08
Last updated
2022-07-08

Locations

1 site across 1 country: Ukraine

Source: ClinicalTrials.gov record NCT05450497. Inclusion in this directory is not an endorsement.